Papaloisou to market Procto-Glyvenol products in Cyprus

The Italian pharmaceutical company Recordati SpA and C.G. Papaloisou Ltd have commenced the marketing and distribution of Procto-Glyvenol cream and Procto-Glyvenol suppositories in Cyprus. Recordati has acquired the marketing authorizations, the brand and the rights to the products from Novartis Consumer Health for a number of Central and Eastern European countries, including Cyprus.

Procto-Glyvenol is indicated for the localized treatment of internal and external hemorrhoids.